Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing, and to examine how they make decisions about their healthcare.
Female patient, age 25 years or older (given that women under this age are not g... [+11]
Previous receipt of any prophylactic mastectomy. [+5]